Not applicableAvailableNCT05522556What this trial is testingPre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)Who this might be right forAlopecia Areata Pfizer
Testing effectiveness (Phase 2)Study completedNCT02197455What this trial is testingTofacitnib for the Treatment of Alopecia Areata and VariantsWho this might be right forAlopecia Areata (AA)Alopecia Totalis (AT)Alopecia Universalis (AU) Yale University 30
Testing effectiveness (Phase 2)Study completedNCT03315689What this trial is testingSafety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)Who this might be right forAlopecia Universalis (AU)Alopecia Totalis (AT) Aclaris Therapeutics, Inc. 11
Testing effectiveness (Phase 2)Ended earlyNCT03759340What this trial is testingATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)Who this might be right forAlopecia AreataAlopecia UniversalisAlopecia Totalis Aclaris Therapeutics, Inc. 56
Post-approval studies (Phase 4)Looking for participantsNCT07381556What this trial is testingCyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness StudyWho this might be right forAlopecia Areata(AA)Alopecia Areata (AA)Alopecia Totalis/Universalis+3 more Erasmus Medical Center 50